Johnson & Johnson Restructuring Reserve
Johnson & Johnson (JNJ) had Restructuring Reserve of $501.00 million as of 2016-01-03, per its 10-K filed 2016-02-24.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2016-02-24
- 2016-01-03: Restructuring Reserve $501.00M.
- 2011-04-03: Restructuring Reserve $304.00M.
- 2011-01-02: Restructuring Reserve $345.00M.
| Period end | Restructuring Reserve |
|---|---|
| 2016-01-03 | $501.00M 10-K · filed 2016-02-24 |
| 2011-04-03 | $304.00M 10-Q · filed 2011-05-10 |
| 2011-01-02 | $345.00M 10-Q · filed 2011-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |